Posts
July 19 2023
BioRestorative Therapies, Inc. announced the closing of its Registered Direct offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.
July 18 2023
First Wave BioPharma, Inc. announced the closing of its Public Offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.
July 18 2023
PARTS iD, Inc., a technology-driven, digital commerce company focused on creating custom infrastructure and unique user experiences within niche markets, announced the closing of their private placement in the amount of $7,000,000. EGS acted as counsel to Titan Partners Group, the sole placement agent for the offering.
July 17 2023
Client Alert: New NYC Law Governing the Use of Artificial Intelligence in Hiring
NYC has passed a law regarding the use of artificial intelligence in hiring and it is being enforced as of July 5, 2023. The law, Local Law 144 (AI Bias Law), prohibits employers from using artificial intelligence (AI) technology to make hiring or promotional decisions unless certain requirements are met.
Click here to read the alert.
July 15 2023
REE Automotive Ltd. announced the commencement of its At The Market Offering in the amount of $35,000,000. EG&S acted as counsel to the Sales Agent.
July 15 2023
Cadrenal Therapeutics, Inc. announced the closing of its Private Placement Offering in the amount of $7,500,000. EG&S acted as counsel to the Placement Agent.
July 14 2023
PainReform Ltd., a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, announced the pricing of its registered direct offering and concurrent private placement in the amount of $2,700,000. EGS acted as counsel to Maxim Group LLC, the exclusive placement agent for the offering.
July 13 2023
IMAC Holdings, Inc. announced the closing of its Private Placement Offering in the amount of $4,300,000. EG&S acted as counsel to the Placement Agent.